Clinical Outcomes of Olmesartan/Rosuvastatin Combination Therapy in Acute Coronary Syndrome Patients With Essential Hypertension

Am J Ther. 2022 Nov-Dec;29(6):e681-e684. doi: 10.1097/MJT.0000000000001292. Epub 2020 Oct 29.

Authors

In-Ho Yang¹, Jin-Man Cho

Affiliation

¹ Department of Cardiology,Kyung Hee University Hospital at Gangdong,Seoul, Republic of Korea.

PMID: 33136578
DOI: 10.1097/MJT.0000000000001292

No abstract available

Publication types

Letter

MeSH terms

Acute Coronary Syndrome* / drug therapy
Antihypertensive Agents / therapeutic use
Blood Pressure
Drug Therapy, Combination
Essential Hypertension / drug therapy
Humans
Hypertension* / drug therapy
Imidazoles / therapeutic use
Rosuvastatin Calcium / therapeutic use
Tetrazoles / therapeutic use
Treatment Outcome

Substances

Rosuvastatin Calcium
olmesartan
Imidazoles
Tetrazoles
Antihypertensive Agents